Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS Vaccine
Impact of HIV-1 genetics on commercial viral load assays examined
September 14th, 2005
Scientists examine the impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays in a recent issue of the Journal of Clinical Microbiology. According to recent research from the United States, "Human immunodeficiency virus type 1 (HIV-1) evolution and changing strain distribution present a challenge to nucleic acid-based assays. Reliable patient monitoring of viral loads requires the detection and accurate quantification of genetically diverse HIV-1." "A panel of 97 HIV-1-seropositive plasma samples collected from Cameroon, Brazil, and South Africa was used to compare the...
Source: Vaccine Weekly (2005-09-14)
|
